Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Post-Market Follow-up Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

NCT01271959 is registered in ClinicalTrials.gov with Precision Therapeutics as lead sponsor.

NCT NCT01271959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01271959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Post-Market Follow-up Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Lead sponsor
Precision Therapeutics
Phase
Observational
Overall status
Terminated
Start date
November 30, 2010
Completion date
October 31, 2012
Enrollment
167 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

solid organ tumors